TY - JOUR AU - Han, L. AU - Zhang, G. F. AU - Cheng, Y. H. AU - Zhao, Q. C. PY - 2016 DA - 2016// TI - Correlations of insulin-like growth factor I and insulin-like growth factor I receptor with the clinicopathological features and prognosis of patients with colon cancer JO - Jpn J Clin Oncol VL - 46 UR - https://doi.org/10.1093/jjco/hyw137 DO - 10.1093/jjco/hyw137 ID - Han2016 ER - TY - JOUR AU - Takahari, D. AU - Yamada, Y. AU - Okita, N. T. AU - Honda, T. AU - Hirashima, Y. AU - Matsubara, J. PY - 2009 DA - 2009// TI - Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer JO - Oncology. VL - 76 UR - https://doi.org/10.1159/000178164 DO - 10.1159/000178164 ID - Takahari2009 ER - TY - JOUR AU - Pandini, G. AU - Frasca, F. AU - Mineo, R. AU - Sciacca, L. AU - Vigneri, R. AU - Belfiore, A. PY - 2002 DA - 2002// TI - Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M202766200 DO - 10.1074/jbc.M202766200 ID - Pandini2002 ER - TY - JOUR AU - Heckl, S. M. AU - Pellinghaus, M. AU - Kruger, S. AU - Bosselmann, C. AU - Wilhelm, F. AU - Behrens, H. M. PY - 2018 DA - 2018// TI - Epithelial insulin receptor expression-prognostic relevance in colorectal cancer JO - Oncotarget. VL - 9 UR - https://doi.org/10.18632/oncotarget.26490 DO - 10.18632/oncotarget.26490 ID - Heckl2018 ER - TY - JOUR AU - Nakamura, M. AU - Miyamoto, S. AU - Maeda, H. AU - Zhang, S. C. AU - Sangai, T. AU - Ishii, G. PY - 2004 DA - 2004// TI - Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-04-0430 DO - 10.1158/1078-0432.CCR-04-0430 ID - Nakamura2004 ER - TY - JOUR AU - Shiratsuchi, I. AU - Akagi, Y. AU - Kawahara, A. AU - Kinugasa, T. AU - Romeo, K. AU - Yoshida, T. PY - 2011 DA - 2011// TI - Expression of IGF-1 and IGF-1R and their relation to clinicopathological factors in colorectal cancer JO - Anticancer Res VL - 31 ID - Shiratsuchi2011 ER - TY - JOUR AU - Becerra, C. R. AU - Salazar, R. AU - Garcia-Carbonero, R. AU - Thomas, A. L. AU - Vazquez-Mazon, F. J. AU - Cassidy, J. PY - 2014 DA - 2014// TI - Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies: a nonrandomized, open-label, phase II trial JO - Cancer Chemother Pharmacol VL - 73 UR - https://doi.org/10.1007/s00280-014-2391-2 DO - 10.1007/s00280-014-2391-2 ID - Becerra2014 ER - TY - JOUR AU - Cohn, A. L. AU - Tabernero, J. AU - Maurel, J. AU - Nowara, E. AU - Sastre, J. AU - Chuah, B. Y. PY - 2013 DA - 2013// TI - A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mdt057 DO - 10.1093/annonc/mdt057 ID - Cohn2013 ER - TY - JOUR AU - Cutsem, E. AU - Eng, C. AU - Nowara, E. AU - Swieboda-Sadlej, A. AU - Tebbutt, N. C. AU - Mitchell, E. PY - 2014 DA - 2014// TI - Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2752 DO - 10.1158/1078-0432.CCR-13-2752 ID - Cutsem2014 ER - TY - STD TI - Sobin LH, Gospodarowicz M, Wittekind C. TNM Classification of Malignant Tumours. 7 ed. Chichester: Wiley-Blackwell; 2009. ID - ref10 ER - TY - JOUR AU - Kononen, J. AU - Bubendorf, L. AU - Kallioniemi, A. AU - Barlund, M. AU - Schraml, P. AU - Leighton, S. PY - 1998 DA - 1998// TI - Tissue microarrays for high-throughput molecular profiling of tumor specimens JO - Nat Med VL - 4 UR - https://doi.org/10.1038/nm0798-844 DO - 10.1038/nm0798-844 ID - Kononen1998 ER - TY - JOUR AU - Remo, A. AU - Fassan, M. AU - Lanza, G. PY - 2016 DA - 2016// TI - Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal JO - Pathologica. VL - 108 ID - Remo2016 ER - TY - JOUR AU - Ogino, S. AU - Kawasaki, T. AU - Brahmandam, M. AU - Yan, L. AU - Cantor, M. AU - Namgyal, C. PY - 2005 DA - 2005// TI - Sensitive sequencing method for KRAS mutation detection by pyrosequencing JO - J Mol Diagn VL - 7 UR - https://doi.org/10.1016/S1525-1578(10)60571-5 DO - 10.1016/S1525-1578(10)60571-5 ID - Ogino2005 ER - TY - JOUR AU - Ii, M. AU - Li, H. AU - Adachi, Y. AU - Yamamoto, H. AU - Ohashi, H. AU - Taniguchi, H. PY - 2011 DA - 2011// TI - The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation status JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-3131 DO - 10.1158/1078-0432.CCR-10-3131 ID - Ii2011 ER - TY - JOUR AU - Romanelli, R. J. AU - LeBeau, A. P. AU - Fulmer, C. G. AU - Lazzarino, D. A. AU - Hochberg, A. AU - Wood, T. L. PY - 2007 DA - 2007// TI - Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphorylation of Akt JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M704309200 DO - 10.1074/jbc.M704309200 ID - Romanelli2007 ER - TY - JOUR AU - Klingbiel, D. AU - Saridaki, Z. AU - Roth, A. D. AU - Bosman, F. T. AU - Delorenzi, M. AU - Tejpar, S. PY - 2015 DA - 2015// TI - Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdu499 DO - 10.1093/annonc/mdu499 ID - Klingbiel2015 ER - TY - JOUR AU - Gkekas, I. AU - Novotny, J. AU - Pecen, L. AU - Strigard, K. AU - Palmqvist, R. AU - Gunnarsson, U. PY - 2017 DA - 2017// TI - Microsatellite instability as a prognostic factor in stage II Colon Cancer patients, a meta-analysis of published literature JO - Anticancer Res VL - 37 ID - Gkekas2017 ER - TY - JOUR AU - Beckwith, H. AU - Yee, D. PY - 2015 DA - 2015// TI - Minireview: were the IGF signaling inhibitors all bad? JO - Mol Endocrinol VL - 29 UR - https://doi.org/10.1210/me.2015-1157 DO - 10.1210/me.2015-1157 ID - Beckwith2015 ER -